Open Source Innovation in the Context of Pharma and Biotech

Open Source Innovation in the Context of Pharma and Biotech

 

RELEASE DATE
09-Jul-2010
REGION
Europe
Research Code: M601-01-00-00-00
SKU: HC01888-EU-MR_06910
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC01888-EU-MR_06910

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

Open Source Innovation in the context of pharma and biotech is an issue based deliverable that gives an overview of this space and analyses the key drivers and barriers of this area. It gives an overview of the key problems faced by the pharmaceutical industry today, past, present and future strategies to tackle these problems, new strategies to improve R&D productivity, advantages of open source innovation, obstacles of this concept, possible solutions to overcome these hurdles, and the future of open source innovation. It also discusses the case studies of some of the major open source innovation initiatives from around the world.

Table of Contents

Analysis of Open Source Innovation in the Context of Pharma and Biotech

  • Overview of Open Source Innovation in the Context of Pharma and Biotech
Related Research
Open Source Innovation in the context of pharma and biotech is an issue based deliverable that gives an overview of this space and analyses the key drivers and barriers of this area. It gives an overview of the key problems faced by the pharmaceutical industry today, past, present and future strategies to tackle these problems, new strategies to improve R&D productivity, advantages of open source innovation, obstacles of this concept, possible solutions to overcome these hurdles, and the future of open source innovation. It also discusses the case studies of some of the major open source innovation initiatives from around the world.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number M601-01-00-00-00
Is Prebook No